Director John Bolger resigns from Fulgent Genetics board effective Sept 24, 2022

Fulgent Genetics, Inc.

John Bolger resigned as director and Audit Committee Chair on Sept 24, 2022.
He also left the Compensation and Nominating & Corporate Governance Committees.
Resignation not due to any disagreement with company operations, policies, or practices.
No replacement has been announced.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

John Bolger

Director

FLGT · Fulgent Genetics, Inc.

Effective: 2022-09-24
Filed: September 29, 2022, 7:59 PM ET

On September 24, 2022, John Bolger notified the Board of Directors (the “Board”) of Fulgent Genetics, Inc. (the “Company”) of his decision to resign from the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

John Bolger resigned as Director at Fulgent Genetics, Inc..

Action: resigned
Role: Director

Exact text from the filing

On September 24, 2022, John Bolger notified the Board of Directors (the “Board”) of Fulgent Genetics, Inc. (the “Company”) of his decision to resign from the Board.

View on SEC.gov

Fulgent Genetics, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-22-019049

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.